Redsense Medical AB (publ) is a Swedish medical technology company focused on enhancing patient safety in the field of hemodialysis therapy. The company's primary innovation is the Redsense System, a device designed to monitor and promptly alert healthcare providers to blood leakage incidents during hemodialysis, specifically addressing the risk of venous needle dislodgement—a critical safety challenge for dialysis patients. This system stands out as the only product in its category with both CE marking and FDA clearance, underscoring its regulatory credibility and reliability for clinical use. Redsense Medical also offers complementary products such as the Redsense venous sensor patch—a noninvasive, fiber-optic solution—and the Redsense Clamp, an accessory that automatically stops blood flow in the event of a complication, regardless of dialysis machine type. While the United States serves as the company's largest and most dynamic market, the firm maintains distribution partnerships across Europe and Canada. By directly addressing significant clinical risks, Redsense Medical AB plays a vital role in improving the quality of life and safety for dialysis patients globally, collaborating closely with major dialysis providers, healthcare professionals, and medical device manufacturers.